Insider Transactions in Q3 2023 at Immunovant, Inc. (IMVT)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 30
2023
|
Peter Salzmann Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
56,774
-2.78%
|
$1,249,028
$22.22 P/Share
|
|
Aug 24
2023
|
Mark S. Levine Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
12,286
-1.88%
|
$245,720
$20.59 P/Share
|
|
Aug 24
2023
|
Julia G. Butchko Chief Development Officer |
SELL
Open market or private sale
|
Direct |
12,333
-1.44%
|
$246,660
$20.59 P/Share
|
|
Aug 24
2023
|
Eva Renee Barnett Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
14,386
-2.06%
|
$287,720
$20.59 P/Share
|
|
Aug 24
2023
|
William L. Macias Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
12,333
-1.76%
|
$246,660
$20.59 P/Share
|
|
Aug 14
2023
|
Peter Salzmann Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
103,058
-4.61%
|
$2,164,218
$21.69 P/Share
|
|
Aug 07
2023
|
Peter Salzmann Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
101,339
-8.23%
|
$2,128,119
$21.73 P/Share
|
|
Jul 26
2023
|
Mark S. Levine Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,917
-1.18%
|
$82,257
$21.63 P/Share
|
|
Jul 19
2023
|
Eva Renee Barnett Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,725
-0.77%
|
$65,400
$24.94 P/Share
|
|
Jul 19
2023
|
William L. Macias Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
426
-0.12%
|
$10,224
$24.94 P/Share
|
|
Jul 12
2023
|
Julia G. Butchko Chief Development Officer |
SELL
Open market or private sale
|
Direct |
1,470
-0.34%
|
$27,930
$19.73 P/Share
|
|
Jul 12
2023
|
Peter Salzmann Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,233
-0.26%
|
$61,427
$19.73 P/Share
|